Trexquant Investment LP Voyager Therapeutics, Inc. Transaction History

Trexquant Investment LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$7.55 - $11.25 $251,777 - $375,165	-33,348 Reduced 75.36%	10,904 $84,000
Q2 2023 Aug 11, 2023	BUY	$6.94 - $13.99 $307,108 - $619,085	44,252 New	44,252 $506,000
Q3 2020 Nov 06, 2020	SELL	$10.01 - $13.75 $307,337 - $422,166	-30,703 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$8.05 - $14.21 $293,607 - $518,281	-36,473 Reduced 54.29%	30,703 $387,000
Q1 2020 May 08, 2020	BUY	$6.8 - $14.66 $311,562 - $671,691	45,818 Added 214.52%	67,176 $615,000
Q4 2019 Feb 12, 2020	BUY	$12.82 - $16.85 $88,932 - $116,888	6,937 Added 48.1%	21,358 $298,000
Q3 2019 Nov 08, 2019	BUY	$16.31 - $28.29 $235,206 - $407,970	14,421 New	14,421 $248,000
Q1 2019 May 13, 2019	SELL	$8.0 - $19.66 $172,032 - $422,768	-21,504 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$8.59 - $18.05 $184,719 - $388,147	21,504 New	21,504 $202,000
Q2 2018 Aug 07, 2018	SELL	$16.76 - $23.92 $292,244 - $417,093	-17,437 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$16.16 - $31.31 $108,061 - $209,369	6,687 Added 62.2%	17,437 $328,000
Q4 2017 Feb 09, 2018	BUY	$12.26 - $25.88 $131,795 - $278,210	10,750	10,750 $178,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.